SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12G - Securities registration termination [Section 12(g)]:
SEC Accession No. 0001193125-23-169963
Filing Date
2023-06-20
Accepted
2023-06-20 13:02:55
Documents
1
Effectiveness Date
2023-06-20

Document Format Files

Seq Description Document Type Size
1 15-12G d461869d1512g.htm 15-12G 10659
  Complete submission text file 0001193125-23-169963.txt   11683
Mailing Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703
Business Address 4819 EMPEROR BOULEVARD SUITE 340 DURHAM NC 27703 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 15-12G | Act: 34 | File No.: 001-39041 | Film No.: 231024291
SIC: 2834 Pharmaceutical Preparations